Activated Clotting Time and Haemostatic Complications in Patients Receiving ECMO Support: A Systematic Review

Activated Clotting Time and Haemostatic Complications in Patients Receiving ECMO Support: A Systematic Review

<b>Background</b>: Extracorporeal membrane oxygenation (ECMO) requires systemic anticoagulation to prevent clotting, typically using unfractionated heparin (UFH). However, anticoagulation carries a bleeding risk, necessitating monitoring. Activated clotting time (ACT) is a commonly used...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel Schwaiger, Lukas Schausberger, Benedikt Treml, Dragana Jadzic, Nicole Innerhofer, Christoph Oberleitner, Zoran Bukumirić, Igor Spurnić, Sasa Rajsic
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
activated clotting time
monitoring
ACT
anticoagulation
extracorporeal membrane oxygenation
ECMO
Online Access:https://www.mdpi.com/2308-3425/12/7/267
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items